385 related articles for article (PubMed ID: 20671744)
21. Serum Fructosamine: A Simple and Inexpensive Test for Assessing Preoperative Glycemic Control.
Shohat N; Tarabichi M; Tischler EH; Jabbour S; Parvizi J
J Bone Joint Surg Am; 2017 Nov; 99(22):1900-1907. PubMed ID: 29135663
[TBL] [Abstract][Full Text] [Related]
22. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
[TBL] [Abstract][Full Text] [Related]
23. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
[TBL] [Abstract][Full Text] [Related]
24. Glycemic Control and Mortality in Diabetic Patients Undergoing Dialysis Focusing on the Effects of Age and Dialysis Type: A Prospective Cohort Study in Korea.
Park JI; Bae E; Kim YL; Kang SW; Yang CW; Kim NH; Lee JP; Kim DK; Joo KW; Kim YS; Lee H
PLoS One; 2015; 10(8):e0136085. PubMed ID: 26285034
[TBL] [Abstract][Full Text] [Related]
25. Correlation between glycated hemoglobin and mean plasma glucose in hemodialysis patients.
Israel E; Geara A; Maarouf O; Ayoub I; Abi Rached J; Rizk S; Staynberg N; Samarneh M; El-Sayegh S
Int Urol Nephrol; 2011 Dec; 43(4):1149-53. PubMed ID: 20658265
[TBL] [Abstract][Full Text] [Related]
26. What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis?
Ichikawa H; Nagake Y; Takahashi M; Nakazono H; Kawabata K; Shikata K; Makino H
Nihon Jinzo Gakkai Shi; 1996 Jul; 38(7):305-8. PubMed ID: 8741392
[TBL] [Abstract][Full Text] [Related]
27. Effects of Hemodialysis and Peritoneal Dialysis on Glycometabolism in Patients with End-Stage Diabetic Nephropathy.
Chen XX; Duan Y; Zhou Y
Blood Purif; 2021; 50(4-5):506-512. PubMed ID: 33302273
[TBL] [Abstract][Full Text] [Related]
28. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
[TBL] [Abstract][Full Text] [Related]
29. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
[TBL] [Abstract][Full Text] [Related]
30. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.
Hoshino J; Hamano T; Abe M; Hasegawa T; Wada A; Ubara Y; Takaichi K; Inaba M; Nakai S; Masakane I;
Nephrol Dial Transplant; 2018 Jul; 33(7):1150-1158. PubMed ID: 29528439
[TBL] [Abstract][Full Text] [Related]
31. Poor glycemic control is a significant predictor of cardiovascular events in chronic hemodialysis patients with diabetes.
Tsujimoto Y; Ishimura E; Tahara H; Kakiya R; Koyama H; Emoto M; Shoji T; Inaba M; Kishimoto H; Tabata T; Nishizawa Y
Ther Apher Dial; 2009 Aug; 13(4):358-65. PubMed ID: 19695075
[TBL] [Abstract][Full Text] [Related]
32. Glycated albumin in diabetic patients with chronic kidney disease.
Zheng CM; Ma WY; Wu CC; Lu KC
Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
[TBL] [Abstract][Full Text] [Related]
33. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
[TBL] [Abstract][Full Text] [Related]
34. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis.
Fukuoka K; Nakao K; Morimoto H; Nakao A; Takatori Y; Arimoto K; Taki M; Wada J; Makino H
Nephrology (Carlton); 2008 Jun; 13(4):278-83. PubMed ID: 18476915
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T; Peng L; Umpierrez GE
Diabetes Care; 2024 Feb; 47(2):267-271. PubMed ID: 38085705
[TBL] [Abstract][Full Text] [Related]
36. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
[TBL] [Abstract][Full Text] [Related]
37. How does CKD affect HbA1c?
Bloomgarden Z; Handelsman Y
J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
[TBL] [Abstract][Full Text] [Related]
38. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy.
Cohen RM; Holmes YR; Chenier TC; Joiner CH
Diabetes Care; 2003 Jan; 26(1):163-7. PubMed ID: 12502674
[TBL] [Abstract][Full Text] [Related]
39. Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease.
Crook ED; Patel S
Ethn Dis; 2006; 16(4):865-71. PubMed ID: 17061739
[TBL] [Abstract][Full Text] [Related]
40. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.
Shafi T; Sozio SM; Plantinga LC; Jaar BG; Kim ET; Parekh RS; Steffes MW; Powe NR; Coresh J; Selvin E
Diabetes Care; 2013 Jun; 36(6):1522-33. PubMed ID: 23250799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
